Role of long-term oxygen therapy in interstitial lung diseases

Role of long-term oxygen therapy in interstitial lung diseases

Abstract Background Long-term oxygen therapy in patients with interstitial lung diseases is frequently given in order to enhance gas exchange, lessen dyspnea, and increase physical activity. Objective To evaluate how individuals with hypoxemia and interstitial lung disease respond to long-term oxyge...

Full description

Bibliographic Details
Main Authors:	Sahar Farghly Yossif, Atef F. El-Qarn, Asmaa M. M. El-Tayeb, Mohamed F. Abd El-Ghany
Format:	Article
Language:	English
Published:	SpringerOpen 2023-10-01
Series:	The Egyptian Journal of Bronchology
Subjects:	LTOT ILD Hypoxemia SMWT SGRQ MMRC
Online Access:	https://doi.org/10.1186/s43168-023-00223-4

Similar Items

Addressing inhaler technique challenges in cognitively impaired chronic obstructive pulmonary disease patients: the impact of customized training programs
by: Vaishnavi V Gaonkar, et al.
Published: (2025-01-01)

Methotrexate Use in Rheumatoid Arthritis-Related Interstitial Lung Disease (RA–ILD): Is It Beneficial?
by: Basma Mohamed Awad Mahmoud, et al.
Published: (2024-07-01)

Changes in blood hemoglobin and blood gases PaO<sub>2</sub> and PaCO<sub>2</sub> in severe COPD overa three-year telemonitored program of long-term oxygen treatment
by: Dal Negro Roberto W, et al.
Published: (2012-07-01)

The diagnostic trajectories of Danish patients with autoimmune rheumatologic disease associated interstitial lung disease: an interview-based study
by: MB Johansen, et al.
Published: (2023-01-01)

Clinical Characteristics and Outcomes of Interstitial Lung Disease Patients with Acute Respiratory Failure Admitted to the ICU
by: Sourabh Pahuja, et al.
Published: (2024-12-01)

Correlating SFTPC gene variants to interstitial lung disease in Egyptian children
by: Azza K. Abdel Megeid, et al.
Published: (2022-08-01)

Systemic and Airway Epigenetic Disruptions Are Associated with Health Status in COPD
by: Ana I. Hernandez Cordero, et al.
Published: (2023-01-01)

Role of sleep questionnaires in predicting obstructive sleep apnea amongst interstitial lung diseases patients
by: Tome Kamgo, et al.
Published: (2023-01-01)

Ambulatory Long-Term Oxygen Therapy in Patients with Severe COPD: A Randomized Crossover Trial to Compare Constant-Minute-Volume and Constant-Bolus Systems
by: Majorski DS, et al.
Published: (2023-11-01)

Prognosis after Intensive Care for COPD Exacerbation in Relation to Long-Term Oxygen Therapy: A Nationwide Cohort Study
by: Helena Nyström, et al.
Published: (2023-12-01)

Disease trajectories in interstitial lung diseases – data from the EXCITING-ILD registry
by: Katharina Buschulte, et al.
Published: (2024-03-01)

Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry
by: Katharina Buschulte, et al.
Published: (2024-01-01)

Clinical impact of pre-existing acute exacerbation in patients with interstitial lung disease who underwent lung transplantation
by: Hyeon Hwa Kim, et al.
Published: (2023-12-01)

Diagnostic Value of Serum KL-6 in Interstitial Lung Diseases
by: Zuo L, et al.
Published: (2024-08-01)

Hormonal harmony disrupted: hypothyroidism and diabetes mellitus in interstitial lung disease. An observational study
by: Manju Bala, et al.
Published: (2024-07-01)

Efficacy and Safety of Nintedanib in Patients with Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD): A Real-World Single Center Experience
by: Maria Boutel, et al.
Published: (2023-03-01)

A rare case of anti-jo1 syndrome presenting as a interstitial lung disease
by: A Kirubanandam, et al.
Published: (2020-01-01)

A Review of MDA-5 Dermatomyositis and Associated Interstitial Lung Disease
by: Sambhawana Bhandari, et al.
Published: (2024-02-01)

How to Utilize CAT and mMRC Scores to Assess Symptom Status of Patients with COPD in Clinical Practice?
by: Esra ERTAN YAZAR, et al.
Published: (2022-06-01)

EFFECTIVENESS OF TRIPLE DRUG FIXED DOSE COMBINATION INHALED THERAPY IN SEVERE COPD PATIENTS
by: Vrunda B Patel, et al.
Published: (2018-03-01)

Influencing factors of good quality of life among chronic obstructive pulmonary disease patients living in Zhejiang Province, China
by: Yubing Ying, et al.
Published: (2024-04-01)

The Quality of Life of Coronavirus Disease Survivors Living in Rural and Urban Area of Riau Province, Indonesia
by: Suyanto Suyanto, et al.
Published: (2022-01-01)

Childhood interstitial lung disease: When to suspect and what to do
by: Grazia Fenu, et al.
Published: (2024-06-01)

30-Day Readmission Rate of Patients with COPD and Its Associated Factors: A Retrospective Cohort Study from a Tertiary Care Hospital
by: Kee YS, et al.
Published: (2023-11-01)

KL-6 in adult polymyositis and dermatomyositis patients and its correlation with interstitial lung disease
by: Mayada Khalil, et al.
Published: (2023-12-01)

Resveratrol attenuates inflammation and fibrosis in rheumatoid arthritis-associated interstitial lung disease via the AKT/TMEM175 pathway
by: Nannan Liu, et al.
Published: (2024-05-01)

Evaluating the diagnostic and therapeutic significance of KL-6 in patients with interstitial lung diseases
by: Ting Wang, et al.
Published: (2024-04-01)

Serum KL-6 levels reflect the severity of interstitial lung disease caused by immune checkpoint inhibitors
by: Xiaoping Li, et al.
Published: (2025-01-01)

Digital Ulceration in a Patient with Interstitial Lung Disease: An Unusual Case of Microscopic Polyangiitis
by: Aliena Badshah, et al.
Published: (2024-06-01)

Efficacy and safety of local ablative therapy for patients with NSCLC and coexisting interstitial lung disease
by: Chuchu Shao, et al.
Published: (2024-04-01)

Quality of life in idiopathic pulmonary fibrosis in Latin American countries
by: H. Aguilar-Duran, et al.
Published: (2025-01-01)

The diffusing capacity of the lungs for carbon monoxide - an independent predictor of interstitial lung disease in patients with rheumatoid arthritis - results of a prospective study
by: Maria-Luciana Anton, et al.
Published: (2023-09-01)

A study on the relationship of dyspnoea score, high-resolution computed tomographic scan, and pulmonary function tests in the evaluation of connective tissue disease-related interstitial lung disorders
by: Somenath Kundu, et al.
Published: (2024-07-01)

Decoding oxygen prescriptions: electronic health record documentation versus patient-reported use
by: Wilson Tang, et al.
Published: (2024-10-01)

Comparison of rituximab vs. cyclophosphamide in rheumatoid arthritis-associated interstitial lung disease and its correlation with spirometry
by: Mohammed Abdullah Saleem, et al.
Published: (2024-12-01)

Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
by: Shih-Ching Lee, et al.
Published: (2024-06-01)

Interstitial Lung Disease in Immunocompromised Children
by: Xianfei Gao, et al.
Published: (2022-12-01)

Resveratrol Ameliorates Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease via the Autophagy–Lysosome Pathway
by: Lanxin Bao, et al.
Published: (2022-12-01)

Connective Tissue Disease‑Associated Interstitial Lung Disease (CTD‑ILD)
by: Cindy Mai
Published: (2024-11-01)

Hydroxychloroquine on the Pulmonary Vascular Diseases in Interstitial Lung Disease: Immunologic Effects, and Virus Interplay
by: Jun-Jun Yeh, et al.
Published: (2022-05-01)